Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
WTW completes acquisition of Cushon, consolidating its position as 4th largest master trust provider in the U.K.
-
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights
-
Joveo Introduces AI Scheduling, Automating Interview Coordination for Candidates and Recruiting Teams
-
Telesat reports results for the quarter ended March 31, 2026
-
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance
-
Brixton Metals Announces Start of Drilling at its Atlin Goldfields Project
-
Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer
-
Apptopia: OSB Mobile Apps Gain Monthly Users but See Engagement Fall
-
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy
-
Kura Oncology to Report First Quarter 2026 Financial Results
-
GD Culture Group Limited Announces Receipt of Preliminary Non-Binding Going Private Proposal at US$10.75 Per Share
-
Intellia Therapeutics to Participate in Upcoming Investor Conferences
-
Winshear Metals Adopts Semi-Annual Financial Reporting
-
BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE
-
EarthDaily Selected by National Reconnaissance Office (NRO) for Commercial Optical Earth Observation Contract
-
Rumble Announces Receipt of all Regulatory Approvals for Business Combination with Northern Data
-
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update
-
NIOB Expands Pegmatite System with Encouraging Niobium and Rare Earth Exploration Indicators
-
Exodus Movement, Inc. to Announce First Quarter 2026 Results on May 12, 2026
-
Cipher Digital Provides First Quarter 2026 Business Update
-
ArcelorMittal announces results of its General Meetings
-
JLT Mobile Computers and Visy at TOC Europe Hamburg – Built for Uptime
-
HII Reports First Quarter 2026 Results
-
Fancamp Exploration Appoints Blake Rhodes to its Board of Directors
-
Sow Good Secures $20 Million Non-Convertible Private Placement Credit Facility to Fund Critical Minerals Strategy
-
Sarah Campbell Joins Future Technologies Venture LLC as Chief Operating Officer
-
Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia
-
Telenor establishes sovereign cloud company
-
Aspocomp Group Plc: Notification of management’s transaction – Manu Skyttä (acquisition)
-
Avista Corp. Reports Q1 2026 Financial Results, Confirms 2026 Utility Earnings Guidance
-
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
-
Gilat Signs Strategic Multimillion Partnership with Nelco in India to Deploy SkyEdge IV
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
-
Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts
-
IREN Announces Acquisition of Mirantis to Strengthen AI Cloud Delivery Capabilities
-
Fiserv Reports First Quarter 2026 Results
-
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BrewDog Announces Partnership with Underbelly as Official Beer Supplier of Underbelly at the Edinburgh Fringe
-
GlobalFoundries Reports First Quarter 2026 Financial Results
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Virtu Financial Connects to zerohash, Further Deepening Institutional-Grade Liquidity for Digital Assets
-
BellRing Brands Reports Results for the Second Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook
-
Orvida Pharma to Present Functional Endpoint Development Data in Rare Palmoplantar Skin Disorders at the 83rd Annual Meeting of the Society for Investigative Dermatology and the 2026 Epidermal Differe
-
Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
-
Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week
-
Lithium Ionic Announces Grant of Management Cease Trade Order and Status Report
-
Shoals Technologies Group, Inc. Reports Financial Results for First Quarter 2026
-
Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies
-
Troilus Upsizes Debt Financing Mandate for up to US$1.2 Billion
